NASDAQ:ALAB • US04626A1034
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ASTERA LABS INC (ALAB).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Loop Capital | Initiate | Buy |
| 2026-02-11 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-15 | RBC Capital | Initiate | Outperform |
| 2025-12-09 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2025-11-20 | BNP PARIBAS EXANE | Initiate | Outperform |
| 2025-11-17 | Northland Capital Markets | Upgrade | Market Perform -> Outperform |
| 2025-11-05 | TD Cowen | Maintains | Hold -> Hold |
| 2025-11-05 | Needham | Maintains | Buy -> Buy |
| 2025-11-05 | Stifel | Maintains | Buy -> Buy |
| 2025-11-05 | Roth Capital | Maintains | Buy -> Buy |
| 2025-11-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-20 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-10-17 | Stifel | Maintains | Buy -> Buy |
| 2025-09-17 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-02 | Deutsche Bank | Maintains | Buy -> Buy |
| 2025-08-29 | CICC | Initiate | Outperform |
| 2025-08-29 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-07 | Susquehanna | Maintains | Neutral -> Neutral |
| 2025-08-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-06 | Needham | Maintains | Buy -> Buy |
| 2025-08-06 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-04 | Stifel | Reiterate | Buy -> Buy |
| 2025-07-30 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 115.794M 44.97% | 396.29M 242.24% | 852.525M 115.13% | 1.372B 60.93% | 1.892B 37.90% | 2.407B 27.22% | 2.596B 7.85% | 2.206B -15.02% | |
| EBITDA YoY % growth | -27.716M 53.33% | -112.912M -307.39% | 180.252M 259.64% | 491.08M 172.44% | 708.45M 44.26% | 946.1M 33.55% | 1.318B 39.31% | N/A | |
| EBIT YoY % growth | -29.497M 51.00% | -116.066M -293.48% | 173.423M 249.42% | 485.28M 179.82% | 738.33M 52.15% | 992.62M 34.44% | 1.306B 31.57% | N/A | |
| Operating Margin | -25.47% | -29.29% | 20.34% | 35.37% | 39.02% | 41.24% | 50.31% | N/A | |
| EPS YoY % growth | N/A | 1.00 | 1.84 84.00% | 2.48 34.94% | 3.51 41.50% | 4.56 29.92% | 6.12 34.05% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.55 65.67% | 0.56 27.22% | 0.62 26.51% | 0.71 22.33% | 0.74 35.42% | 0.79 41.74% | 0.85 37.28% | 0.89 25.99% |
| Revenue Q2Q % growth | 297.91M 86.85% | 315.35M 64.31% | 310.48M 34.65% | 349.86M 29.30% | 373.88M 25.50% | 394.86M 25.21% | 418.4M 34.76% | 438.85M 25.44% |
| EBITDA Q2Q % growth | 97.749M 687.66% | 99.116M 134.37% | 126.51M 113.02% | 158.51M 114.82% | 151.32M 54.80% | 159.99M 61.42% | 170.9M 35.09% | 171.67M 8.30% |
| EBIT Q2Q % growth | 103.47M 816.88% | 107.46M 170.18% | 123.06M 122.11% | 143.85M 114.84% | 156.01M 50.78% | 166.81M 55.23% | 179.73M 46.05% | 189.38M 31.65% |
All data in USD
28 analysts have analysed ALAB and the average price target is 206.23 USD. This implies a price increase of 71.39% is expected in the next year compared to the current price of 120.33.
ASTERA LABS INC (ALAB) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of ASTERA LABS INC (ALAB) is 0.55 USD and the consensus revenue estimate is 297.91M USD.
The expected long term growth rate for ASTERA LABS INC (ALAB) is 41.59%.